• Deliver robust data-driven operational strategy recommendations from the Request for Proposal stage through to the end of the site ID process in order to drive successful study endpoints• Develop strong relationships with all internal and external customers, ensuring clear communication channels are maintained at all times• Conduct data mining of internal and external databases to develop robust strategies for conducting clinical trials and make recommendations for geographical placement (country/site mix) • Participate in Site ID assessments by setting initial strategy at the time of the RFP, creating site assessment surveys, overseeing creation of the optimal site profile and site list development, reviewing data from sites, determining parameters for tiering sites and providing PSV recommendations

• Functioned as a feasibility strategist with the Site and Patient Access team. Assessed internal and external data sources to optimize country and site selection. Assisted in site outreach to determine investigator interest and patient populations. • Functioned as a clinical scientist on the Global Product Development team. Performed a variety of tasks, including competitive landscape and enrollment rate analysis for, interim efficacy and safety assessments for ongoing trials and evaluation of prescribing data to inform trial design • Worked with the regulatory affairs team to improve aspects of the RegView system in the areas of expanded access and rare diseases • Assisted with scientific writing, including creation of a Pharmacy Manual and authoring an article in the Evidera Global Regulatory intelligence Digest (GRiD) publication

• Prepared documents for IRB submission including informed consent forms, case report forms and schedule of events forms • Recruited test subjects for an investigator-initiated clinical trial and participated in collection of samples during study visits and maintenance of case report forms • Assisted in preparation and analysis of tissue and blood samples for evaluation of antiretroviral concentrations • Assisted in the creation and presentation of a continuing education webinar for health professionals on novel delivery systems for HIV medications • Functioned as primary author on a peer-reviewed publication about the use of darunavir in pregnant women with HIV

• Operated small emission chambers to characterize indoor air pollutants • Modified chamber testing apparatus to fit objectives of primary investigators and to troubleshoot problems • Collected air samples with sorbent medias and performed liquid extraction for analysis • Operated analytical instruments including HPLC (Agilent 1100/Chemstation) and LC/MS/MS (API 3200/Analyst) • Analyzed data in Microsoft Excel and assisted in report writing for publications